Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycosis Fungoides | 15 | 2022 | 163 | 3.140 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 14 | 2021 | 207 | 2.700 |
Why?
|
Sezary Syndrome | 10 | 2022 | 76 | 2.600 |
Why?
|
Skin Neoplasms | 20 | 2021 | 5686 | 1.190 |
Why?
|
Dermatitis, Atopic | 9 | 2021 | 654 | 1.160 |
Why?
|
Epidermis | 4 | 2019 | 528 | 0.860 |
Why?
|
Keratinocytes | 13 | 2022 | 798 | 0.840 |
Why?
|
Interleukins | 4 | 2019 | 791 | 0.690 |
Why?
|
Aminoquinolines | 3 | 2017 | 109 | 0.650 |
Why?
|
Activins | 1 | 2019 | 208 | 0.630 |
Why?
|
Chemokines, CXC | 1 | 2017 | 422 | 0.520 |
Why?
|
Mouth Mucosa | 1 | 2018 | 434 | 0.510 |
Why?
|
Skin | 12 | 2022 | 4364 | 0.490 |
Why?
|
Chemokines | 1 | 2017 | 970 | 0.430 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 604 | 0.380 |
Why?
|
Up-Regulation | 5 | 2019 | 4217 | 0.360 |
Why?
|
Oxonic Acid | 1 | 2009 | 41 | 0.350 |
Why?
|
Tegafur | 1 | 2009 | 49 | 0.350 |
Why?
|
Receptors, CCR4 | 2 | 2019 | 81 | 0.320 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.300 |
Why?
|
Colitis, Ulcerative | 1 | 2018 | 1912 | 0.270 |
Why?
|
Th2 Cells | 3 | 2021 | 1061 | 0.250 |
Why?
|
Stomach Neoplasms | 2 | 2017 | 1333 | 0.250 |
Why?
|
Galectins | 2 | 2019 | 268 | 0.250 |
Why?
|
Psoriasis | 3 | 2017 | 898 | 0.250 |
Why?
|
Dermatitis | 2 | 2017 | 197 | 0.250 |
Why?
|
Pruritus | 2 | 2017 | 361 | 0.230 |
Why?
|
Cisplatin | 1 | 2009 | 1662 | 0.220 |
Why?
|
Case-Control Studies | 12 | 2021 | 21746 | 0.210 |
Why?
|
RNA, Messenger | 9 | 2019 | 13033 | 0.200 |
Why?
|
Chemokine CCL17 | 1 | 2021 | 23 | 0.200 |
Why?
|
Cytokines | 5 | 2022 | 7322 | 0.200 |
Why?
|
Cyclophilin A | 1 | 2021 | 57 | 0.200 |
Why?
|
Antigens, Neoplasm | 2 | 2022 | 1988 | 0.190 |
Why?
|
Serpins | 1 | 2022 | 247 | 0.190 |
Why?
|
Prednisolone | 2 | 2018 | 334 | 0.180 |
Why?
|
Receptors, CCR3 | 1 | 2019 | 62 | 0.180 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11031 | 0.170 |
Why?
|
Anticarcinogenic Agents | 1 | 2021 | 253 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2915 | 0.170 |
Why?
|
4-1BB Ligand | 1 | 2018 | 29 | 0.170 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 41 | 0.160 |
Why?
|
Serum Amyloid A Protein | 1 | 2018 | 121 | 0.160 |
Why?
|
GATA6 Transcription Factor | 1 | 2018 | 50 | 0.160 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 44 | 0.160 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2017 | 23 | 0.160 |
Why?
|
Middle Aged | 27 | 2021 | 213383 | 0.160 |
Why?
|
Staphylococcal Skin Infections | 1 | 2018 | 75 | 0.160 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 250 | 0.160 |
Why?
|
Purpura | 1 | 2018 | 122 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 342 | 0.160 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2017 | 906 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.150 |
Why?
|
Chemokine CCL4 | 1 | 2017 | 128 | 0.150 |
Why?
|
HMGB1 Protein | 1 | 2018 | 133 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2017 | 126 | 0.150 |
Why?
|
Interleukin-4 | 2 | 2017 | 1147 | 0.150 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2635 | 0.150 |
Why?
|
Syndecan-4 | 1 | 2016 | 44 | 0.150 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 625 | 0.140 |
Why?
|
Chemokine CCL5 | 1 | 2017 | 209 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11524 | 0.140 |
Why?
|
Pemphigoid, Bullous | 1 | 2018 | 109 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 820 | 0.140 |
Why?
|
HTLV-I Infections | 1 | 2016 | 101 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2017 | 3508 | 0.140 |
Why?
|
Thyroiditis | 1 | 2016 | 85 | 0.140 |
Why?
|
Chemokine CX3CL1 | 1 | 2016 | 58 | 0.140 |
Why?
|
Biopsy | 5 | 2019 | 6756 | 0.140 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 310 | 0.140 |
Why?
|
Vitiligo | 1 | 2016 | 89 | 0.130 |
Why?
|
Drug Eruptions | 1 | 2018 | 297 | 0.130 |
Why?
|
Cell Proliferation | 6 | 2021 | 10481 | 0.130 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 166 | 0.130 |
Why?
|
Stomatitis | 1 | 2018 | 269 | 0.130 |
Why?
|
Azepines | 1 | 2017 | 336 | 0.130 |
Why?
|
Japan | 2 | 2016 | 1360 | 0.130 |
Why?
|
Scleroderma, Localized | 1 | 2015 | 79 | 0.120 |
Why?
|
Male | 28 | 2021 | 350118 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 582 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2018 | 250 | 0.120 |
Why?
|
Alopecia Areata | 1 | 2016 | 107 | 0.120 |
Why?
|
Humans | 46 | 2023 | 744343 | 0.120 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 769 | 0.120 |
Why?
|
Macrophages | 3 | 2018 | 5655 | 0.120 |
Why?
|
Proteoglycans | 1 | 2017 | 835 | 0.120 |
Why?
|
Interleukin-1 | 1 | 2018 | 1263 | 0.120 |
Why?
|
Chemotaxis | 1 | 2017 | 607 | 0.120 |
Why?
|
Receptors, Virus | 1 | 2017 | 648 | 0.110 |
Why?
|
Interferon-alpha | 1 | 2017 | 895 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8428 | 0.110 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1364 | 0.110 |
Why?
|
Th17 Cells | 1 | 2019 | 766 | 0.110 |
Why?
|
Receptors, Chemokine | 1 | 2016 | 669 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.110 |
Why?
|
Tumor Escape | 1 | 2015 | 349 | 0.110 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 570 | 0.110 |
Why?
|
Disease Progression | 5 | 2019 | 13284 | 0.100 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 561 | 0.100 |
Why?
|
Female | 26 | 2021 | 380194 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2017 | 899 | 0.100 |
Why?
|
Triazoles | 1 | 2017 | 911 | 0.100 |
Why?
|
Brazil | 1 | 2015 | 1270 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1607 | 0.090 |
Why?
|
Aged | 16 | 2023 | 163280 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.090 |
Why?
|
Colonoscopy | 1 | 2018 | 1367 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1772 | 0.090 |
Why?
|
Oxazolone | 2 | 2019 | 60 | 0.090 |
Why?
|
Adult | 16 | 2019 | 214055 | 0.090 |
Why?
|
Antigen Presentation | 1 | 2015 | 1284 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 855 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2017 | 1850 | 0.090 |
Why?
|
Immunohistochemistry | 5 | 2020 | 11366 | 0.080 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15540 | 0.080 |
Why?
|
Young Adult | 7 | 2019 | 56430 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 2 | 2018 | 573 | 0.070 |
Why?
|
Lymphoma | 1 | 2015 | 1877 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12959 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2017 | 4479 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10180 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2019 | 16689 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5510 | 0.060 |
Why?
|
Drug Combinations | 1 | 2009 | 1959 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3474 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6103 | 0.060 |
Why?
|
Mice | 7 | 2019 | 81183 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.060 |
Why?
|
Animals | 11 | 2021 | 168757 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6773 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7880 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18029 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 21827 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2017 | 19229 | 0.050 |
Why?
|
Down-Regulation | 2 | 2021 | 3002 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9734 | 0.050 |
Why?
|
Tetrahydronaphthalenes | 1 | 2021 | 89 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 371 | 0.050 |
Why?
|
Chemotactic Factors | 1 | 2021 | 199 | 0.050 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2020 | 16 | 0.050 |
Why?
|
Tumor Burden | 2 | 2017 | 1915 | 0.050 |
Why?
|
Receptors, CCR10 | 1 | 2019 | 10 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13695 | 0.040 |
Why?
|
Croton Oil | 1 | 2019 | 3 | 0.040 |
Why?
|
Water Loss, Insensible | 1 | 2019 | 12 | 0.040 |
Why?
|
Desmosomes | 1 | 2019 | 73 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2021 | 300 | 0.040 |
Why?
|
beta-Defensins | 1 | 2018 | 57 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4386 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 732 | 0.040 |
Why?
|
Skin Diseases, Infectious | 1 | 2018 | 74 | 0.040 |
Why?
|
Calgranulin A | 1 | 2018 | 79 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2019 | 14557 | 0.040 |
Why?
|
Ultraviolet Therapy | 1 | 2018 | 81 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2019 | 237 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8436 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2728 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 712 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1381 | 0.040 |
Why?
|
Growth Substances | 1 | 2019 | 784 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 424 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.040 |
Why?
|
Leucovorin | 1 | 2018 | 628 | 0.040 |
Why?
|
Cell Movement | 2 | 2019 | 5217 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 730 | 0.040 |
Why?
|
Caspases | 1 | 2019 | 928 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2017 | 534 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 209 | 0.030 |
Why?
|
Blotting, Southern | 1 | 2016 | 803 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 793 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2017 | 328 | 0.030 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 259 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1821 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 261 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 8863 | 0.030 |
Why?
|
Gastroscopy | 1 | 2017 | 207 | 0.030 |
Why?
|
Arm | 1 | 2018 | 589 | 0.030 |
Why?
|
Camptothecin | 1 | 2018 | 576 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1880 | 0.030 |
Why?
|
Nose | 1 | 2018 | 509 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1588 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2016 | 389 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15997 | 0.030 |
Why?
|
Endothelial Cells | 2 | 2017 | 3479 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1619 | 0.030 |
Why?
|
Eosinophils | 1 | 2018 | 955 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 1000 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2018 | 1041 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1641 | 0.030 |
Why?
|
Cyclins | 1 | 2015 | 603 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2015 | 844 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2886 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 85781 | 0.030 |
Why?
|
Scalp | 1 | 2015 | 380 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21683 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2716 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 1856 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3870 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20129 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1451 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1941 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 1602 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6622 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4751 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1903 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2133 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1900 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Mast Cells | 1 | 2015 | 1544 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3299 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 77449 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2541 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5535 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1889 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3462 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13102 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 40075 | 0.020 |
Why?
|
DNA Methylation | 1 | 2018 | 4286 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4420 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9583 | 0.020 |
Why?
|
Recurrence | 1 | 2015 | 8340 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6234 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5853 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
Transcription Factors | 1 | 2017 | 12208 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63114 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 57776 | 0.010 |
Why?
|